Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M20,137Revenue (TTM) $M816Net Margin (%)--Altman Z-Score--
Enterprise Value $M--EPS (TTM) $0.9Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M76.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PCYC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCYCMario Gabelli 2015-06-30 Sold Out -0.04%$253.71 - $261.25
($256.7)
$ 261.252%Sold Out0
PCYCMario Gabelli 2015-03-31 Buy 0.04%$119.85 - $258.35
($193.06)
$ 261.2535%New holding27,750
PCYCJoel Greenblatt 2015-03-31 Sold Out -0.0026%$119.85 - $258.35
($193.06)
$ 261.2535%Sold Out0
PCYCKen Fisher 2015-03-31 Sold Out -0.0008%$119.85 - $258.35
($193.06)
$ 261.2535%Sold Out0
PCYCJoel Greenblatt 2014-12-31 Buy $103.79 - $141.55
($128.16)
$ 261.25104%New holding2,619
PCYCJoel Greenblatt 2014-09-30 Sold Out -0.09%$91.5 - $127.81
($114.49)
$ 261.25128%Sold Out0
PCYCKen Fisher 2014-09-30 Reduce$91.5 - $127.81
($114.49)
$ 261.25128%Reduce -36.57%3,244
PCYCJoel Greenblatt 2014-06-30 Add0.08%$85.85 - $107.42
($93.89)
$ 261.25178%Add 724.62%79,089
PCYCMariko Gordon 2014-06-30 Sold Out -0.04%$85.85 - $107.42
($93.89)
$ 261.25178%Sold Out0
PCYCKen Fisher 2014-06-30 Buy $85.85 - $107.42
($93.89)
$ 261.25178%New holding5,114
PCYCMariko Gordon 2014-03-31 Add0.02%$100.49 - $151.61
($129.71)
$ 261.25101%Add 112.41%9,295
PCYCJoel Greenblatt 2014-03-31 Buy 0.01%$100.49 - $151.61
($129.71)
$ 261.25101%New holding9,591
PCYCMariko Gordon 2013-12-31 Add0.01%$99.28 - $139.59
($121.32)
$ 261.25115%Add 130.07%4,376
PCYCMariko Gordon 2013-09-30 Buy 0.01%$84.5 - $132.49
($110.93)
$ 261.25136%New holding1,902
PCYCJoel Greenblatt 2013-03-31 Sold Out -0.14%$57.78 - $94.2
($77.47)
$ 261.25237%Sold Out0
PCYCJoel Greenblatt 2012-12-31 Buy 0.14%$47.87 - $69.78
($58.72)
$ 261.25345%New holding41,832
PCYCGeorge Soros 2012-06-30 Sold Out -0.04%$25.72 - $53.44
($32.62)
$ 261.25701%Sold Out0
PCYCGeorge Soros 2012-03-31 Buy 0.04%$14.99 - $28.68
($20.91)
$ 261.251149%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCYC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


PCYC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Soni Manmeet SinghCFO 2015-03-13Sell27,514$254.242.76view
Tan HeowChief Quality&Tech Operations 2015-03-12Sell1,000$254.512.65view
Zanganeh MakyCOO 2015-03-11Sell30,000$254.112.81view
Zanganeh MakyCOO 2015-03-11Sell30,000$254.112.81view
Fardis MariaChief of Oncology Ops & Allian 2014-11-13Sell3,000$141.384.89view
Soni Manmeet SinghCFO 2014-11-13Sell1,000$141.4484.71view
Zanganeh MakyCOO 2014-11-12Sell30,482$134.6993.96view
Love Richard BGeneral Counsel 2014-11-10Sell1,500$133.8795.15view
Fardis MariaChief of Oncology Ops & Allian 2014-11-07Sell5,000$134.594.24view
Zanganeh MakyCOO 2014-09-04Sell12,000$121.75114.58view

Quarterly/Annual Reports about PCYC:

    News about PCYC:

    Articles On GuruFocus.com
    Several Companies Reach 52-Week Highs Sep 20 2016 
    Mindich Continues Pattern of Selling More Stakes Than He Buys Sep 15 2015 
    PRIMECAP Sells Stake in Biopharmaceutical Company Aug 28 2015 
    Eric Mindich Increases His Most Valuable Stake in First Quarter Jun 12 2015 
    AbbVie Floats Mega-Bond Deal For Acquisition Funding May 08 2015 
    Wall Street’s Best and Worst Calls of the First Quarter 2015 May 07 2015 
    Pharmacyclics Posts A Mixed First Quarter Ahead Of Being Acquired By AbbVie May 07 2015 
    AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board Apr 24 2015 
    Weekly Insider Sells Highlight: PCYC, DIS, AZO, SCI Mar 17 2015 
    AbbVie Strikes The Biggest Deal For Treatment Of Cancer Mar 10 2015 

    More From Other Websites
    Several Companies Reach 52-Week Highs Sep 20 2016
    Medivation Is for Sale: How Much Should It Get? May 13 2016
    Tax Savvy Execs Work For $1, Get Paid Millions As Capital Gain May 02 2016
    Tax Savvy Execs Work For $1, Get Paid Millions As Capital Gain May 02 2016
    Ibrutinib (IMBRUVICA®) Improved Survival for Treatment–Naïve Chronic Lymphocytic Leukemia... Jan 07 2016
    Ibrutinib (IMBRUVICA®) Improved Survival for Treatment–Naïve Chronic Lymphocytic Leukemia... Jan 07 2016
    Why AbbVie Should Be Worth 25% More Aug 10 2015
    Abbvie completes $21 billion buyout of Pharmacyclics May 26 2015
    The Most Loved Biotechs of Big Hedge Funds May 23 2015
    Abbvie specifies breakdown of $21 billion Pharmacyclics deal May 21 2015
    Pharmacyclics (PCYC), DIRECTV (DTV), Actavis (ACT): Farallon Capital Betting On Merger Arb Plays May 19 2015
    Borrowers warned: Don't be fooled by high grade market resilience May 11 2015
    Pharmacyclics tops 1Q profit forecasts May 01 2015
    Biz Break: The 2015 SV150: Apple in command, Wall Street has demands Apr 24 2015
    Pharmacyclics, Inc. (PCYC), Horizon Pharma PLC (HZNP), Auspex Pharmaceuticals Inc (ASPX): Hedge... Apr 02 2015
    Pharmacyclics cancer drug successful as combination therapy - independent panel Mar 16 2015
    FDA panel recommends unblinding study after Imbruvica shows clear benefit Mar 16 2015
    Biz Break: Pharmacyclics cofounder on $21B buyout -- 'This is a company that kept fighting' Mar 05 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)